Shinya Ohkouchi Selected Research

Idiopathic Pulmonary Fibrosis

1/2011

Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinya Ohkouchi Research Topics

Disease

12	Pulmonary Alveolar Proteinosis 01/2023 - 01/2012
5	Lung Neoplasms (Lung Cancer) 01/2021 - 09/2002
5	Neoplasms (Cancer) 08/2014 - 09/2002
4	Fibrosis (Cirrhosis) 01/2023 - 01/2012
3	Emphysema 01/2023 - 01/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 01/2017
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2012
2	Lung Diseases (Lung Disease) 01/2021 - 01/2020
2	Rare Diseases (Rare Disease) 01/2020 - 08/2017
1	Sarcopenia 05/2024
1	Malnutrition (Nutritional Deficiencies) 05/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2024
1	Sarcoidosis (Schaumann Disease) 10/2022
1	Lymphadenopathy 10/2022
1	COVID-19 10/2022
1	Giant Cell Granuloma (Peripheral Giant Cell Granuloma) 10/2022
1	Uveitis 10/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Inflammation (Inflammations) 01/2018
1	Adenocarcinoma of Lung 06/2017
1	Adenocarcinoma 06/2017
1	Reperfusion Injury 04/2017
1	Infections 08/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 12/2012
1	Acute Lung Injury 01/2011
1	Idiopathic Pulmonary Fibrosis 01/2011
1	Lung Injury 01/2011
1	Hypersensitivity (Allergy) 09/2002

Drug/Important Bio-Agent (IBA)

7	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2023 - 04/2014
7	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 01/2012
6	Surface-Active Agents (Surfactants)IBA 01/2021 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 08/2017 - 01/2011
2	Messenger RNA (mRNA)IBA 10/2022 - 11/2003
2	Phosphates (Orthophosphate)IBA 01/2021 - 01/2011
2	EpitopesIBA 11/2003 - 09/2002
2	Protein Subunit VaccinesIBA 11/2003 - 09/2002
2	Peptides (Polypeptides)IBA 11/2003 - 09/2002
1	Indicators and Reagents (Reagents)IBA 05/2024
1	IndiumIBA 01/2023
1	indium tin oxideIBA 01/2023
1	BNT162 VaccineIBA 10/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2022
1	NucleosidesIBA 10/2022
1	SARS-CoV-2 spike proteinIBA 10/2022
1	VaccinesIBA 10/2022
1	Mitochondrial Uncoupling ProteinsIBA 01/2022
1	Smad7 ProteinIBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	CalciumIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2019
1	sargramostim (Leukine)FDA Link 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	AutoantibodiesIBA 08/2017
1	DNA (Deoxyribonucleic Acid)IBA 06/2017
1	ErbB Receptors (EGF Receptor)IBA 06/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2015
1	CollagenIBA 01/2015
1	SuspensionsIBA 08/2014
1	Transcription Factors (Transcription Factor)IBA 08/2014
1	Fibroblast Growth Factor 10IBA 08/2014
1	human FGF10 proteinIBA 08/2014
1	Conditioned Culture MediaIBA 08/2014
1	AntibodiesIBA 12/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2012
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	HMGB1 Protein (HMG1)IBA 01/2011
1	Pancreatic Elastase (Elastase)IBA 01/2011
1	CytokinesIBA 01/2011
1	Chemokine CX3CL1IBA 05/2005
1	LigandsIBA 05/2004
1	OX40 LigandIBA 05/2004
1	AntigensIBA 11/2003
1	HLA-B52 AntigenIBA 11/2003
1	cyclophilin BIBA 09/2002

Therapy/Procedure

6	Therapeutics 06/2017 - 05/2005
2	Lung Transplantation 01/2020 - 04/2017
2	Immunotherapy 05/2004 - 11/2003
1	Transplantation 01/2023
1	Respiratory Therapy (Therapy, Respiratory) 01/2020
1	Subcutaneous Injections 04/2014
1	Aftercare (After-Treatment) 05/2005